Par Pharmaceutical Success Story

Études de cas
Par Pharmaceutical faced the challenge of complying with a Food & Drug Administration (FDA) ruling that required drug product labels be submitted in XML. By mandating that pharmaceutical companies adopt XML, the FDA’s ruling was disruptive, adding cost and complexity to the process of bringing products to market. In response to the ruling, Par, a developer and manufacturer of generic and proprietary specialty drugs, turned to Quark for an in-house XML authoring solution that allows the team to achieve compliance quickly, easily, and cost-effectively.